APTEVO THERAPEUTICS INC (APVO) Stock News

USA - NASDAQ:APVO - US03835L5049 - Common Stock

1.08 USD

-0.14 (-11.48%)

Last: 11/20/2025, 8:00:00 PM

1.09 USD

+0.01 (+0.93%)

Pre-Market: 11/21/2025, 4:55:00 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

APVO Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Zacks Investment Research

Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

11 days ago - By: ACCESS Newswire

Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors

15 days ago - By: ACCESS Newswire

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

a month ago - By: ACCESS Newswire

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

a month ago - By: Benzinga - Mentions: SNWV CLRB SPRB GLTO ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

2 months ago - By: ACCESS Newswire

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

3 months ago - By: ACCESS Newswire

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

3 months ago - By: The Motley Fool

Aptevo Reports 85% Remission in Q2

a month ago - By: Benzinga - Mentions: SNWV ONMD GLMD PCSA ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

3 months ago - By: ACCESS Newswire

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

2 months ago - By: Stocktwits

Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort

3 months ago - By: ACCESS Newswire - Mentions: FMST

Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

3 months ago - By: ACCESS Newswire

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

3 months ago - By: ACCESS Newswire - Mentions: SXTP

Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

4 months ago - By: Yahoo Finance

Aptevo Meets Nasdaq $2.5M Equity Requirement